Mother-infant Microbiota Transmission and Its Link to the Health of the Baby
1 other identifier
observational
20,000
1 country
1
Brief Summary
The human intestinal tract harbors a diverse and complex microbial community, known as gut microbiota, which is critical in sustaining physiology, metabolism, nutrition and immune function. Dysbiosis of gut microbiota has been linked with obesity, hyperglycemia, hyperlipidemia, inflammatory bowel disease and other chronic inflammatory diseases. Gut microbiota is affected by host genetic markup, diet and life style; and therefore varied by human races and geographical locations. The development of gut microbiota starts before birth. The infant's microbiome can impact on human health in later life. The microbiome of pregnant women are associated with early-life microbiota of their offspring as well as growth, neurodevelopment and the development of allergic and neurocognitive disorders. Early childhood, when the microbiota is less mature and more malleable, is a golden age for microbiota manipulation to prevent disease. Studying microbiota at this golden age also allow us to dissect the development of a faulty microbiota and identify therapeutic targets to reverse it and cure diseases that are already developed.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Sep 2019
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 23, 2019
CompletedFirst Submitted
Initial submission to the registry
October 3, 2019
CompletedFirst Posted
Study publicly available on registry
October 7, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 2, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
October 2, 2027
May 29, 2024
May 1, 2024
7 years
October 3, 2019
May 26, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Develop a 100,000 pair of mother-baby longitudinal cohort
Set up a large scale database to collect data such as comprehensive clinical data, such as mother's and father's demographic and clinical information (e.g. age, weight, gender, family medical history, dietary, drug usage etc.)
8 year
Secondary Outcomes (2)
Dissect the important microbiome that maintain health
8 year
Seize the golden period of early life for prevention of human diseases
8 year
Study Arms (3)
Pregnant women
Women who are being pregnant and plan to give birth in local hospital. Pregnant women who plan to stay in the same local area for at least 7 years post-delivery.
New Born Baby
new born baby of an enrolled pregnant woman.
Father of new born baby
Biological father of an enrolled new born baby.
Eligibility Criteria
This project will consist of a total 100,000 mother-baby pairs from all centers in 7 years. The study is exploratory in nature. In considering the number of events required for reliable quantification of different factors on a range of diseases, we decided to include 100,000 mother-baby pairs.
You may qualify if:
- Being pregnant
- Plan to give birth in local hospital
- Competent to provide informed consent (no mental illness or dementia, etc. that will hinder their ability to undertake informed consent)
You may not qualify if:
- Be a new born baby of an enrolled pregnant woman
- Biological father of an enrolled new born baby
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Prince of Wales Hospital
Hong Kong, Hong Kong, China
Biospecimen
Blood, urine, stool, saliva, hair, nail, nasopharyngeal swab, skin swab, buccal swab, placenta, cord blood, low Vaginal swab and breast milk samples
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
October 3, 2019
First Posted
October 7, 2019
Study Start
September 23, 2019
Primary Completion (Estimated)
October 2, 2026
Study Completion (Estimated)
October 2, 2027
Last Updated
May 29, 2024
Record last verified: 2024-05